Cargando…
P119 CPAP and adverse cardiovascular events in OSA: Are participants of randomized trials representative of sleep clinic patients?
INTRODUCTION: Randomized controlled trials (RCTs) have shown no reduction in adverse cardiovascular (CV) events in patients randomized to continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA). This study examined whether randomized study populations were representative...
Autores principales: | Reynor, A, McArdle, N, Shenoy, B, Dhaliwal, S, Rea, S, Walsh, J, Eastwood, P, Maddison, K, Hillman, D, Ling, I, Keenan, B, Maislin, G, Magalang, U, Pack, A, Mazzotti, D, Lee, R, Singh, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109361/ http://dx.doi.org/10.1093/sleepadvances/zpab014.160 |
Ejemplares similares
-
O054 What Measure of CPAP Treatment is most closely Associated with Reduced Risk of Future Major Cardiovascular Events (MACE)?
por: Reynor, A, et al.
Publicado: (2023) -
P124 Chronotype and OSA combine to modify risk of hypertension
por: Sansom, K, et al.
Publicado: (2021) -
O006 Major adverse cardiovascular events in severe Obstructive Sleep Apnoea: Associations with symptom subtypes and symptom burden
por: Shenoy, B, et al.
Publicado: (2023) -
P103 Associations between sleep regularity, OSA and hypertension in a middle-aged community population
por: Sansom, K, et al.
Publicado: (2022) -
OSA: Treatments beyond CPAP
por: Cammaroto, Giovanni, et al.
Publicado: (2022)